Yamada Yoshihiro, Wang Xiang-Di, Yokoyama Shin-ichiro, Fukuda Noboru, Takakura Nobuyuki
Department of Stem Cell Biology, Cancer Research Institute, Kanazawa University, Takarama-chi 13-1, Kanazawa 920-0934, Japan.
Biochem Biophys Res Commun. 2006 Apr 7;342(2):662-70. doi: 10.1016/j.bbrc.2006.01.181. Epub 2006 Feb 10.
Cardiomyocyte (CM) regeneration is limited in adult life and is not sufficient to prevent myocardial infarction. Hence, the identification of a useful source of CM progenitors is of great interest for possible use in regenerative therapy. Mesenchymal stem cells in bone marrow, embryonic stem cells, and skeletal myoblasts are known sources of CM repletion; however, there are a number of critical problems for clinical application. In this study, we succeeded to identify CM progenitor cells in brown adipose tissue (BAT). Moreover, we showed that CM progenitor cells in BAT that existed in CD29-positive population could differentiate into CM with high efficiency. To confirm the in vivo effect of CD29(+)BAT-derived cells (BATDCs), we transplanted these cells into infarct border zone of an acute myocardial infarction model in rat. Results clearly indicated that implantation of CD29(+) BATDCs led to the reduction of the infarction area and improvement of left ventricular function by replacing newly developed CMs in comparison with that by CD29(+) white adipose tissue-derived cells or control saline. These findings suggest that BATDCs are one of the useful sources for a new strategy in CM regeneration.
成年期心肌细胞(CM)的再生能力有限,不足以预防心肌梗死。因此,寻找一种有用的CM祖细胞来源对于再生治疗的潜在应用具有重要意义。骨髓间充质干细胞、胚胎干细胞和骨骼肌成肌细胞是已知的CM补充来源;然而,临床应用存在一些关键问题。在本研究中,我们成功地在棕色脂肪组织(BAT)中鉴定出CM祖细胞。此外,我们发现存在于CD29阳性群体中的BAT中的CM祖细胞能够高效分化为CM。为了证实CD29(+)BAT来源细胞(BATDCs)的体内作用,我们将这些细胞移植到大鼠急性心肌梗死模型的梗死边缘区。结果清楚地表明,与CD29(+)白色脂肪组织来源细胞或对照生理盐水相比,植入CD29(+)BATDCs可通过替代新生成的CM导致梗死面积减小和左心室功能改善。这些发现表明,BATDCs是CM再生新策略的有用来源之一。